Vapor nanobubbles rapidly detect malaria through the skin
January 2, 2014
Rice University researchers have developed a noninvasive technology that accurately detects even a single malaria-infected cell among a million normal cells through the skin in seconds with a laser scanner.
The “vapor nanobubble” technology requires no dyes or diagnostic chemicals, there is no need to draw blood, and there are zero false-positive readings.
The diagnosis and screening will be supported by a low-cost, battery-powered portable device that can be operated by non-medical personnel. One device should be able to screen up to 200,000 people per year, with the cost of diagnosis estimated to be below 50 cents, the researchers say.
The new diagnostic technology uses a low-powered laser that creates tiny vapor “nanobubbles” inside malaria-infected cells. The bursting bubbles have a unique acoustic signature that allows for an extremely sensitive diagnosis.
The transdermal diagnostic method takes advantage of the optical properties and nanosize of hemozoin, a nanoparticle produced by a malaria parasite inside red blood cell. Hemozoin crystals are not found in normal red blood cells.
Lead investigator Dmitri Lapotko, a Rice scientist who invented the vapor nanobubble technology, a faculty fellow in biochemistry and cell biology and in physics and astronomy at Rice, and lead co-author Ekaterina Lukianova-Hleb found that hemozoin absorbs the energy from a short laser pulse and creates a transient vapor nanobubble.
This short-lived vapor nanobubble emerges around the hemozoin nanoparticle and is detected both acoustically and optically. In the study, the researchers found that acoustic detection of nanobubbles made it possible to detect malaria with extraordinary sensitivity.
“Ours is the first through-the-skin method that’s been shown to rapidly and accurately detect malaria in seconds without the use of blood sampling or reagents,’ said Lapotko
Lapotko said the first trials of the technology in humans are expected to begin in Houston in early 2014.
Malaria, one of the world’s deadliest diseases, sickens more than 300 million people and kills more than 600,000 each year, most of them young children. Despite widespread global efforts, malaria parasites have become more resistant to drugs, and efficient epidemiological screening and early diagnosis are largely unavailable in the countries most affected by the disease.
Inexpensive rapid diagnostic tests exist, but they lack sensitivity and reliability. The gold standard for diagnosing malaria is a “blood smear” test, which requires a sample of the patient’s blood, a trained laboratory technician, chemical reagents and high-quality microscope. These are often unavailable in low-resource hospitals and clinics in the developing world.
Abstract of Proceedings of the National Academy of Sciences paper
Successful diagnosis, screening, and elimination of malaria critically depend on rapid and sensitive detection of this dangerous infection, preferably transdermally and without sophisticated reagents or blood drawing. Such diagnostic methods are not currently available. Here we show that the high optical absorbance and nanosize of endogenous heme nanoparticles called “hemozoin,” a unique component of all blood-stage malaria parasites, generates a transient vapor nanobubble around hemozoin in response to a short and safe near-infrared picosecond laser pulse. The acoustic signals of these malaria-specific nanobubbles provided transdermal noninvasive and rapid detection of a malaria infection as low as 0.00034% in animals without using any reagents or drawing blood. These on-demand transient events have no analogs among current malaria markers and probes, can detect and screen malaria in seconds, and can be realized as a compact, easy-to-use, inexpensive, and safe field technology.